HUMANIZED ANTI-C5A ANTIBODIES AND USES THEREOF
Provided is inhibition of the complement signaling using a humanized anti-C5a antibody. Provided are methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with the humanized anti-C5a antibody. L'invention concerne l'...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ZHANG, Jianjun QI, Shigang SONG, Wenchao MIWA, Takashi TSUI, Ping GULLIPALLI, Damodara Rao ZHU, Xihua SATO, Sayaka |
| description | Provided is inhibition of the complement signaling using a humanized anti-C5a antibody. Provided are methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with the humanized anti-C5a antibody.
L'invention concerne l'inhibition de la signalisation du complément à l'aide d'un anticorps anti-C5a humanisé. L'invention concerne des méthodes de traitement d'une maladie médiée par le complément ou d'un trouble médié par le complément chez un individu par la mise en contact de l'individu avec l'anticorps anti-C5a humanisé. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023051642A8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023051642A8</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023051642A83</originalsourceid><addsrcrecordid>eNrjZNDzCPV19POMcnVRcPQL8dR1NnUEM5z8XTxdg4FMF4XQYCAjxMM1yNXfjYeBNS0xpziVF0pzMyi7uYY4e-imFuTHpxYXJCan5qWWxIf7GxkYGRuYGpqZGDlaGBOnCgBYTyZe</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HUMANIZED ANTI-C5A ANTIBODIES AND USES THEREOF</title><source>esp@cenet</source><creator>ZHANG, Jianjun ; QI, Shigang ; SONG, Wenchao ; MIWA, Takashi ; TSUI, Ping ; GULLIPALLI, Damodara Rao ; ZHU, Xihua ; SATO, Sayaka</creator><creatorcontrib>ZHANG, Jianjun ; QI, Shigang ; SONG, Wenchao ; MIWA, Takashi ; TSUI, Ping ; GULLIPALLI, Damodara Rao ; ZHU, Xihua ; SATO, Sayaka</creatorcontrib><description>Provided is inhibition of the complement signaling using a humanized anti-C5a antibody. Provided are methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with the humanized anti-C5a antibody.
L'invention concerne l'inhibition de la signalisation du complément à l'aide d'un anticorps anti-C5a humanisé. L'invention concerne des méthodes de traitement d'une maladie médiée par le complément ou d'un trouble médié par le complément chez un individu par la mise en contact de l'individu avec l'anticorps anti-C5a humanisé.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231207&DB=EPODOC&CC=WO&NR=2023051642A8$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231207&DB=EPODOC&CC=WO&NR=2023051642A8$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHANG, Jianjun</creatorcontrib><creatorcontrib>QI, Shigang</creatorcontrib><creatorcontrib>SONG, Wenchao</creatorcontrib><creatorcontrib>MIWA, Takashi</creatorcontrib><creatorcontrib>TSUI, Ping</creatorcontrib><creatorcontrib>GULLIPALLI, Damodara Rao</creatorcontrib><creatorcontrib>ZHU, Xihua</creatorcontrib><creatorcontrib>SATO, Sayaka</creatorcontrib><title>HUMANIZED ANTI-C5A ANTIBODIES AND USES THEREOF</title><description>Provided is inhibition of the complement signaling using a humanized anti-C5a antibody. Provided are methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with the humanized anti-C5a antibody.
L'invention concerne l'inhibition de la signalisation du complément à l'aide d'un anticorps anti-C5a humanisé. L'invention concerne des méthodes de traitement d'une maladie médiée par le complément ou d'un trouble médié par le complément chez un individu par la mise en contact de l'individu avec l'anticorps anti-C5a humanisé.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDzCPV19POMcnVRcPQL8dR1NnUEM5z8XTxdg4FMF4XQYCAjxMM1yNXfjYeBNS0xpziVF0pzMyi7uYY4e-imFuTHpxYXJCan5qWWxIf7GxkYGRuYGpqZGDlaGBOnCgBYTyZe</recordid><startdate>20231207</startdate><enddate>20231207</enddate><creator>ZHANG, Jianjun</creator><creator>QI, Shigang</creator><creator>SONG, Wenchao</creator><creator>MIWA, Takashi</creator><creator>TSUI, Ping</creator><creator>GULLIPALLI, Damodara Rao</creator><creator>ZHU, Xihua</creator><creator>SATO, Sayaka</creator><scope>EVB</scope></search><sort><creationdate>20231207</creationdate><title>HUMANIZED ANTI-C5A ANTIBODIES AND USES THEREOF</title><author>ZHANG, Jianjun ; QI, Shigang ; SONG, Wenchao ; MIWA, Takashi ; TSUI, Ping ; GULLIPALLI, Damodara Rao ; ZHU, Xihua ; SATO, Sayaka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023051642A83</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHANG, Jianjun</creatorcontrib><creatorcontrib>QI, Shigang</creatorcontrib><creatorcontrib>SONG, Wenchao</creatorcontrib><creatorcontrib>MIWA, Takashi</creatorcontrib><creatorcontrib>TSUI, Ping</creatorcontrib><creatorcontrib>GULLIPALLI, Damodara Rao</creatorcontrib><creatorcontrib>ZHU, Xihua</creatorcontrib><creatorcontrib>SATO, Sayaka</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHANG, Jianjun</au><au>QI, Shigang</au><au>SONG, Wenchao</au><au>MIWA, Takashi</au><au>TSUI, Ping</au><au>GULLIPALLI, Damodara Rao</au><au>ZHU, Xihua</au><au>SATO, Sayaka</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HUMANIZED ANTI-C5A ANTIBODIES AND USES THEREOF</title><date>2023-12-07</date><risdate>2023</risdate><abstract>Provided is inhibition of the complement signaling using a humanized anti-C5a antibody. Provided are methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with the humanized anti-C5a antibody.
L'invention concerne l'inhibition de la signalisation du complément à l'aide d'un anticorps anti-C5a humanisé. L'invention concerne des méthodes de traitement d'une maladie médiée par le complément ou d'un trouble médié par le complément chez un individu par la mise en contact de l'individu avec l'anticorps anti-C5a humanisé.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2023051642A8 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | HUMANIZED ANTI-C5A ANTIBODIES AND USES THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T11%3A38%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHANG,%20Jianjun&rft.date=2023-12-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023051642A8%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |